Compare ALEMBIC PHARMA with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA STERLING BIOTECH ALEMBIC PHARMA/
STERLING BIOTECH
 
P/E (TTM) x 16.7 -0.4 - View Chart
P/BV x 6.6 0.0 46,608.6% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   STERLING BIOTECH
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
STERLING BIOTECH
Dec-13
ALEMBIC PHARMA/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs66411 6,323.8%   
Low Rs4123 12,129.4%   
Sales per share (Unadj.) Rs208.726.8 778.6%  
Earnings per share (Unadj.) Rs31.0-15.0 -207.2%  
Cash flow per share (Unadj.) Rs37.1-5.5 -679.3%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.254.9 262.8%  
Shares outstanding (eoy) m188.52267.87 70.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.60.3 994.6%   
Avg P/E ratio x17.4-0.5 -3,736.5%  
P/CF ratio (eoy) x14.5-1.3 -1,139.9%  
Price / Book Value ratio x3.70.1 2,946.9%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,4611,862 5,449.9%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m7,467547 1,365.6%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m39,3477,181 548.0%  
Other income Rs m9443 220.2%   
Total revenues Rs m39,4417,223 546.0%   
Gross profit Rs m8,736947 922.6%  
Depreciation Rs m1,1522,543 45.3%   
Interest Rs m1844,377 4.2%   
Profit before tax Rs m7,493-5,931 -126.3%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568-1,924 -81.5%   
Profit after tax Rs m5,844-4,007 -145.9%  
Gross profit margin %22.213.2 168.4%  
Effective tax rate %20.932.4 64.5%   
Net profit margin %14.9-55.8 -26.6%  
BALANCE SHEET DATA
Current assets Rs m19,57714,335 136.6%   
Current liabilities Rs m14,89649,809 29.9%   
Net working cap to sales %11.9-494.0 -2.4%  
Current ratio x1.30.3 456.7%  
Inventory Days Days90403 22.2%  
Debtors Days Days45171 26.6%  
Net fixed assets Rs m27,09755,432 48.9%   
Share capital Rs m377268 140.7%   
"Free" reserves Rs m26,81113,935 192.4%   
Net worth Rs m27,18814,701 184.9%   
Long term debt Rs m4,9939,478 52.7%   
Total assets Rs m47,77873,988 64.6%  
Interest coverage x41.7-0.4 -11,748.3%   
Debt to equity ratio x0.20.6 28.5%  
Sales to assets ratio x0.80.1 848.6%   
Return on assets %12.60.5 2,518.8%  
Return on equity %21.5-27.3 -78.9%  
Return on capital %23.6-6.4 -367.3%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m19,4531,860 1,046.0%   
Fx outflow Rs m6,06525 24,366.4%   
Net fx Rs m13,3881,835 729.6%   
CASH FLOW
From Operations Rs m8,1201,719 472.4%  
From Investments Rs m-7,556-3,148 240.0%  
From Financial Activity Rs m5901,426 41.4%  
Net Cashflow Rs m1,153-3 -33,920.6%  

Share Holding

Indian Promoters % 74.1 33.9 218.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.0 -  
FIIs % 9.1 9.9 91.9%  
ADR/GDR % 0.0 16.9 -  
Free float % 13.9 39.3 35.4%  
Shareholders   49,328 21,482 229.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   ASTRAZENECA PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Plunged 1,708 Points Today(Closing)

Indian share markets witnessed huge selling pressure today as fears that the government could go for stricter lockdowns.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Apr 12, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - NOVARTIS COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS